乙型肝炎重症化的概念及自然史

郭威; 李维娜; 宁琴

doi:10.3969/j.issn.1001-5256.2014.10.001

乙型肝炎重症化的概念及自然史

DOI: 10.3969/j.issn.1001-5256.2014.10.001

华中科技大学同济医学院附属同济医院感染科

详细信息

中图分类号: R512.62;R575.3
计量
- 文章访问数: 2245
- HTML全文浏览量: 5
- PDF下载量: 799
- 被引次数: 0
出版历程
- 收稿日期: 2014-09-01
- 出版日期: 2014-10-20

The definition and natural history of severe exacerbation of hepatitis B

Department of Infectious Diseases, Tongji Hospital, Huazhong University of Science and Technology Tongji Medical College

摘要

摘要:
尽管多年来国内外学术界有关肝衰竭的定义和分类等多个问题存在着不同的看法,但近年来对肝衰竭的命名、分型和临床诊断方面的认识已逐渐趋于一致。介绍了肝衰竭的分型、乙型肝炎重症化的概念及发生、发展的自然史,指出早期抗病毒治疗和人工肝支持治疗对其结局和预后有积极的影响。
- 肝炎病毒,乙型 /
- 肝炎,乙型,慢性 /
- 肝功能衰竭
Abstract:
Despite different opinions on its definition and classification in the past, a consensus has gradually been reached regarding the naming, classification, and clinical diagnosis of liver failure. The classification of liver failure is described, and the definition and natural history of severe exacerbation of hepatitis B are summarized. Antiviral treatment and artificial liver support in the early stage are beneficial for clinical outcomes and prognosis.
- hepatitis B virus /
- hepatitis B, chronic /
- liver failure

HTML全文

参考文献(25)

[1] NING Q, CHEN Z, WANG YM.Acute exacerbation of chronic hepatitis:basic research and clinical management[M].Wuhan:Huazhong University of Science and Technology Press, 2014:1-756. (in Chinese) 宁琴, 陈智, 王宇明.乙型肝炎重症化基础与临床[M].武汉:华中科技大学出版社, 2014:1-756.

[2]O'GRADY JG, SCHALM SW, WILLIAMS R.Acute liver failure:redefining the syndromes[J].Lancet, 1993, 342 (8866) :273-275.

[3]BERNUAU J, RUEFF B, BENHAMOU JP.Fulminant and subfulminant liver failure:defnitions and causes[J].Semin Liver Dis, 1986, 6 (2) :97-106.

[4]GIMSON AE, O'GRADY JG, EDE RJ, et al.Late onset hepatic failure:clinical, serological and histological features[J].Hepatology, 1986, 6 (2) :288-294.

[5]MAS A, RODS J.Fulminant hepatic failure[J].Lancet, 1997, 349 (9058) :1081-1085.

[6]BERNAL W, AUZINGER G, DHAWAN A, et al.Acute liver failure[J].Lancet, 2010, 376 (9736) :190-201.

[7]WANG YM, CHEN YK, GU CH, et al.Reevaluation of the nomenclature and diagnostic criteria in 477 patients with severe hepatitis[J].Chin J Hepatol, 2000, 8 (5) :261-263. (in Chinese) 王宇明, 陈耀凯, 顾长海, 等.重型肝炎命名和诊断分型的再认识——附477例临床分析[J].中华肝脏病杂志, 2000, 8 (5) :261-263.

[8]POLSON J, LEE WM.American Association for the Study of Liver Disease.AASLD position paper:the management of acute liver failure[J].Hepatology, 2005, 41 (5) :1179-1197.

[9]Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases.Chinese Medical Association;Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association.Diagnostic and treatment guidelines for liver failure[J].Chin J Hepatol, 2006, 14 (9) :643-646. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组、中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].中华肝脏病杂志, 2006, 14 (9) :643-646.

[10]LEE WM, SQUIRES RH JR, NYBERG SL, et al.Acute liver failure:summary of a workshop[J].Hepatology, 2008, 47 (4) :1401-1415.

[11]LARSON AM.Diagnosis and management of acute liver failure[J].Curr Opin Gastroenterol, 2010, 26 (3) :214-221

[12]SARIN SK, KUMAR A, ALMEIDA JA, et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) [J].Hepatol Int, 2009, 3 (1) :269-282.

[13]LI LJ.Artificial liver[M].Zhejiang:Zhejiang University Press, 2012:1-439. (in Chinese) 李兰娟.人工肝脏[M].浙江:浙江大学出版社, 2012:1-439.

[14]LIU C, WANG YM, FAN K.Epidemiological and clinical features of hepatitis B virus related liver failure in China[J].World J Gastroenterol, 2011, 17 (25) :3054-3059.

[15]KE WM, LI XJ, YU LN, et al.Etiological investigation of fatal liver failure during the course of chronic hepatitis B in south east China[J].J Gastroenterol, 2006, 41 (4) :347-351.

[16]TANG H, MCLACHLAN A.Transcriptional regulation of hepatitis B virus by nuclear hormone receptor is a critical determinant of viral tropism[J].Pro Natl Acad Sci U S A, 2001, 98 (4) :1841-1846.

[17]LONG Y, CHEN E, LIU C, et al.The correlation of hepatocyte nuclear factor 4 alpha and 3 beta with hepatitis B virus replication in the liver of chronic hepatitis B patients[J].J Viral Hepat, 2009, 16 (8) :537-546.

[18]HAN M, YAN W, GUO W, et al.Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway[J].J Biol Chem, 2008, 283 (47) :32715-32729.

[19]RAHIMI RS, ROCKEY DC.Complications and outcomes in chronic liver disease[J].Curr Opin Gastroenterol, 2011, 27 (3) :204-209.

[20]HEATHCOTE EJ.Demography and Presentation of Chronic Hepatitis B Virus Infection[J].Am J Med, 2008, 121 (12 Suppl) :s3-s11.

[21]WURSTHORN K, WEDEMEYER H, MANNS MP.Managing HBV in patients with impaired immunity[J].Gut, 2010, 59 (10) :1430-1445.

[22]AGARWAL M, COTTAM S.Laboratory tests in hepatic failure[J].Anasthesia Inten Care Med, 2009, 10 (7) :326-327.

[23]OLIVER S, van FLORIAN B, JRGEN KR, et al.Current and Future therapies for chronic HBV-infections[J].Reviews Med Microbiol, 2007, 18:79-88.

[24]MA K, GUO W, HAN M, et al.Entecavir treatment prevents dis ease progression in hepatitis B virus-related acute-on-chronic liver failure:establishment of a novel logistical regression model[J].Hepatol Int, 2012, 6 (4) :735-743.

[25] Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.Guidelines for nonbioartificial liver support system in the treatment of liver failure (2009) [J].Chin J Clin Infect Dis, 2009, 2 (6) :321-325. (in Chinese) 中华医学会感染病学分会肝衰竭与人工肝学组.非生物型人工肝支持系统治疗肝衰竭指南 (2009年版) [J].中华临床感染病杂志, 2009, 2 (6) :321-325.

施引文献

资源附件(0)

访问统计